Recent Clinical/Technology Distribution of Medtech Startups

Since January 2011, we have identified 158 medical technology companies that have been founded globally. As in the past when we have discussed “medtech” companies, whether in the context of startups or in fundings, we would like to make clear what we define as medtech:

What is “medtech”?: We view medical technology (medtech) as principally medical devices and equipment, but also all technologies that are directly competitive with or complementary to technologies represented by therapeutic or diagnostic medical devices/equipment.
Since January 2011, we have identified 158 medical technology companies that have been founded globally. As in the past when we have discussed “medtech” companies, whether in the context of startups or in fundings, we would like to make clear what we define as medtech:
What is “medtech”?: We view medical technology (medtech) as principally medical devices and equipment, but also all technologies that are directly competitive with or complementary to technologies represented by therapeutic or diagnostic medical devices/equipment.
An enormous range of technologies are under development at this company (see our detailed list of technologies from past years at link). For the sake of our database subscribers interested only in specific clinical/technology areas, we categorize the companies accordingly (based on the nature of their technologies or clinical application). Below is represented the distribution of technologies at the companies identified from 2011 to May 2013. Note, please, that multiple clinical/technology categories are possible for each company, so the pie chart below represents the whole not as the total number of companies, but a multiple of the number of companies and clinical/technology areas.
Source: MedMarket Diligence, LLC; Medtech Startups Database.

Author

PatrickDriscoll

I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

View all posts by PatrickDriscoll